ADAM9 and hepatocellular carcinoma: In HCC cells, MICA shedding was shown to be mediated by ADAM9, ADAM10, and ADAM17 [7], wherein regorafenib inhibits MICA shedding by decreasing mRNA levels of ADAM9 and ADAM10 [16].